By Pat Shafer, Managing Director, Grant Thornton LLP Dec 31, 2019 Everyone is searching for opportunities to leverage artificial intelligence (AI). To date, relatively few opportunities identified in regulatory and quality areas seem to be paying off. Some efforts have focused on voice-initiated queries: “Hey Google, will I need to file a variation in Chile if I change environmental controls in the packaging area?” Others have focused on extracting what could be structured product data embedded deeply within submissions documents in preparation for eventual Identification of Medicinal Products (IDMP) implementation. One company explored AI as a means of mapping their dossier in the hope of identifying redundant content and consolidating to a more concise submission. Of the dozens of such attempts this author has witnessed, none has proven an unqualified success. Part of the problem is lack of focus. In each case, Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||